Ultrasound Devices Market Outlook:
Ultrasound Devices Market size was over USD 10.7 billion in 2025 and is estimated to reach USD 16.2 billion by the end of 2035, expanding at a CAGR of 4.7% during the forecast timeline, i.e., 2026-2035. In 2026, the industry size of ultrasound devices is assessed at USD 11.2 billion.
The technological advancements within the ultrasound devices, such as portability and miniaturisation of the products, have significantly increased the demand for screening of different diseases. The portability has enabled doorstep screening of patients, enabling wider adoption of the devices globally. Moreover, with the latest features such as 2D and 3D screenings, healthcare practitioners can now effectively assess and monitor the patient's conditions and prescribe a diagnosis. The rise in radiology screenings has also increased because of the rise in cancer cases, as ultrasound devices can effectively screen the internal organs through soundwaves to depict an image.
The World Health Organisation, in February 2024, predicted a rise of 35 million new cancer cases by 2050, a 77% rise from 2022. The growing prevalence of cancer cases and effective screening methods has increased the demand for the market. Countries across North America and the Asia Pacific are expecting a rise in chronic diseases, including leukaemia and breast cancer, because of cultural influences leading to a rise in these diseases. These diseases require screening that allows practitioners to assess the impacted areas through ultrasound devices. According to data from the World Cancer Research Fund 2022, China had the highest number of cancer cases, which is expected to increase in the future, demonstrating the potential growth prospect for the market.
Key Ultrasound Devices Market Insights Summary:
Regional Highlights:
- North America in the ultrasound devices market is projected to capture a 30.2% share by 2035, attributed to rising cancer incidence, increasing healthcare expenditure and reimbursements, and rapid integration of AI-enabled ultrasound technologies improving diagnostic decision-making.
- Asia Pacific is expected to register the fastest growth through 2035, supported by low-cost manufacturing hubs, expanding adoption of portable and handheld devices, and strong government investments in healthcare and diagnostic infrastructure.
Segment Insights:
- Radiology application in the ultrasound devices market is projected to account for a 22.8% share by 2035, supported by the rising burden of cancer cases and accelerated adoption of AI-enabled precision imaging enhancing emergency and screening efficiency.
- Hospital end use is expected to dominate the market by 2035 as expanding patient inflow across cardiology, obstetrics, and emergency care amplifies reliance on safe, non-invasive, and portable ultrasound systems across clinical settings.
Key Growth Trends:
- Growth in cardiovascular cases
- Increased demand for non-invasive imaging
Major Challenges:
- High cost of advanced devices
- Technological limitations
Key Players: GE Healthcare (U.S.), Philips Healthcare (Netherlands), Siemens Healthineers (Germany), Canon Medical Systems (Japan), Mindray (China), FUJIFILM SonoSite (U.S.), Samsung Medison (South Korea), Hitachi Healthcare (Japan), Clarius Mobile Health (Canada), Esaote (Italy).
Global Ultrasound Devices Market Forecast and Regional Outlook:
Market Size & Growth Projections:
- 2025 Market Size: USD 10.7 billion
- 2026 Market Size: USD 11.2 billion
- Projected Market Size: USD 16.2 billion by 2035
- Growth Forecasts: 4.7% CAGR (2026-2035)
Key Regional Dynamics:
- Largest Region: North America (30.2% share by 2035)
- Fastest Growing Region: Asia Pacific
- Dominating Countries: United States, China, Germany, Japan, United Kingdom
- Emerging Countries: India, Brazil, South Korea, Mexico, Indonesia
Last updated on : 10 February, 2026
Ultrasound Devices Market – Growth Drivers and Challenges
Growth Drivers
- Growth in cardiovascular cases: Cardiovascular diseases have risen in the past few years, which requires the support of echocardiography, producing soundwaves to generate a real-time graph, allowing practitioners to understand the rhythm of the heartbeat and the functioning of the heart components. According to the World Health Organization, in July 2025, more than 19.8 million people died because of CVDs in 2022, showing the rising threat from cardiovascular diseases, demanding effective detection of anomalies. An echocardiogram is an effective method that assesses multiple factors apart from heart rhythm, which helps enhance preventive measures.
- Increased demand for non-invasive imaging: Ultrasound devices ensure pain-free screening of the internal components, leading to widespread adoption in different clinical settings. Unlike CT scans and MRI, ultrasound devices do not use contrasting agents, making the imaging process safer, especially for pregnant women and children. It allows real-time monitoring and is often used in fetal assessment and movements to determine the position and other parameters of the fetus, enabling quicker decisions and improving positive outcomes. The device is highly effective in scanning patients in resuscitation, which demands a quick assessment of the heart condition and allows preparation for preventive measures. The ultrasound devices allow fast and effective decision-making, enabling higher survival chances of patients.
- Accessible healthcare infrastructure: The growth in the middle class has fueled the inclusion of ultrasound devices in healthcare settings. As the healthcare system improves, demand for ultrasound imaging grows, fueling the growth of the market. The growing demand for ultrasound devices has increased competition within the healthcare sector, leading to a reduction in the prices of screenings, increasing the adoption of ultrasound screenings. According to the IBEF, in January 2025, the disposable income of India is predicted to rise by USD 4.34 thousand by 2029, demonstrating the growing middle class willing to afford premium healthcare services.
Challenges
- High cost of advanced devices: Older ultrasound devices are low on maintenance and function at lesser cost. However, the inclusion of 2D and 3D screenings elevated the cost, leading to a decline in adoption. For countries with a low healthcare budget, integration of such systems can be challenging, reducing the scope of the market. Finding skilled technicians also challenges the adoption of the ultrasound devices market, as advanced devices require technicians to have a thorough understanding of the process and the medical complexities.
- Technological limitations: Despite advancements within the ultrasound devices, the image resolution is often poor when compared to the images of MRI and CT scans. To scrutinise a specific disease, practitioners often advise MRI and CT scans, which show clearer and broader prictures which helps in assessing the patient better. The preference for MRI and CT scan-based images over ultrasound devices is significantly declining, restricting the growth of the global market.
Ultrasound Devices Market Size and Forecast:
| Report Attribute | Details |
|---|---|
|
Base Year |
2025 |
|
Forecast Period |
2026-2035 |
|
CAGR |
4.7% |
|
Base Year Market Size (2025) |
USD 10.7 billion |
|
Forecast Year Market Size (2035) |
USD 16.2 billion |
|
Regional Scope |
|
Ultrasound Devices Market Segmentation:
Application Market Analysis
The radiology segment is anticipated to hold the largest share of 22.8% by the end of 2035 due to the large number of cancer cases, which demand precision imaging and high-quality resolutions. The integration of AI within radiology screening has enabled the growth of the segment. Ultrasonic devices can screen during an emergency situation and generate images with ease, unlike other systems that take time to generate images. Healthcare infrastructure is heavily investing in AI-based ultrasound that brings positive patient outcomes. Point-of-care ultrasound is a growing technology that is used in emergency settings to scan the patient's trauma, which is supporting the expansion of the market.
End Use Segment Analysis
The hospital segment is expected to hold the largest share owing to the growing demand from hospitals where multiple patients arrive for their varied medical needs. Ultrasound devices are used in various applications, including cardiology, where the heart rate and rhythm are effectively measured. Ultrasound is a crucial method that is used to measure the fetus's size and orientation, as it is highly safe and does not include any form of invasion. The soundwaves are light and do not harm the fetus's growth, impacting positive growth for the market. Hospitals also employ portable devices in OPD settings, which fuels the demand for the market and supports accelerating the growth in the global markets.
Product Segment Analysis
The diagnostic segment is anticipated to hold the largest market share by the end of 2035, owing to the wide-scale application including oncology, cardiology and obstetrics. The segment will further propel because of rising technological advancements and the changing nature of diseases that demand screening of the internal organs to assess the impact and begin with diagnosis. As cardiology disorders have increased over the period of time, valve blockages and heart failures are commonly witnessed within patients, which demand instant imaging and resuscitation to increase the survival chances. The use of ultrasound devices in the diagnostic screening of health challenges has widely impacted the growth of the market.
Our in-depth analysis of the ultrasound market includes the following segments:
|
Segment |
Subsegments |
|
Application |
|
|
Portability |
|
|
End use |
|
|
Product |
|
Vishnu Nair
Head - Global Business DevelopmentCustomize this report to your requirements — connect with our consultant for personalized insights and options.
Ultrasound Devices Market- Regional Analysis
North America Market Insights
The ultrasound devices market in North America is anticipated to hold a share of 30.2% by the end of 2035, owing to the rising cancer cases. The lifestyle changes have impacted the patients severely, fueling the growth of ultrasound devices. The region is also experiencing a rise in healthcare expenditure and reimbursements, enabling patients to undergo ultrasound scanning, enhancing the growth of the North America market. Key players in the region further support the expansion of the market through innovative and cost-effective devices. The players in the market have introduced AI within ultrasound devices, which enhances decision-making and takes preventive measures.
In the U.S., the rising prevalence of cardiovascular cases within the country is driving the growth of the ultrasound devices market. The country has also accelerated in terms of research and development, where advanced ultrasound devices are developed. In April 2025, Philips developed its first-ever AI-enabled ultrasound imaging platform to address diagnostic efficiency. The system will allow the practitioners to investigate and monitor the patient's condition remotely, enabling positive patient outcomes.
The large population of Canada often experiences health disorders where the need for imaging becomes essential. Canada is also experiencing growth in cancer cases, which ramped up the adoption of radiology imaging, fueling the growth of the market in the region. Key players such as Hitachi Healthcare have advanced their products in cardiology and neurology, which enables effective treatment and diagnosis. The business is also collaboratively working with the Canadian hospitals to enable the healthcare professionals enhance remote monitoring.
APAC Market Insights
APAC is expected to grow the fastest owing to the low-cost manufacturing of ultrasound devices. Certain countries in the region are hubs of manufacturing, leading to a lower cost of manufacturing and enabling wider adoption of ultrasound devices. To meet the demand from a large population, healthcare facilities are employing portable and hand-held devices to seamlessly serve patients. The government is heavily investing in the healthcare and diagnostic centre to meet the rising demand of the population and to diagnose complex diseases. Specifically, the gynaecological issues have increased over the period of time, leading to preventive care and high-resolution imaging to assess the patient conditions better, amplifying the growth of the market in the Asia Pacific.
China is investing largely under Healthy China 2030, leading to innovation and modernisation of medical equipment, including screening systems such as ultrasound devices. China is a leader in the production of low-cost products, especially medical devices, supporting the growth of the market. The cases of cancer are rising within the region, which is demanding accurate diagnosis to enhance patient care and disease detection. The key players of the market are developing advanced ultrasound devices that are backed by AI, leading to an enhancement within the China market.
India is also experiencing a boom within the healthcare segment because of the rising population. The healthcare facilities shrank during the pandemic, which pressured the government to improve the healthcare infrastructure and enhance accessibility for patients. The sudden growth in the infrastructure pushed the growth of ultrasound devices and other equipment. The changing lifestyle and cultural factors have influenced the health of the population adversely, leading to a rise in chronic diseases that demand ultrasound scanning, amplifying the growth of India market.
Europe Market Insights
Europe has a strong market for ultrasound devices as it focuses on quality of care and ascertains positive patient outcomes. The agencies, such as the NHS, continuously implement and monitor the ultrasound devices that can enhance the quality of care. AI-powered ultrasound has been introduced, which can reduce diagnostic errors through improved scanning. AI has also supported enhanced decision-making as it provides an analysis of the patient's condition and predicts the next steps, enabling healthcare professionals to reduce time in complex ideation. Cardiovascular diseases remain the leading cause of death in Europe, which has strengthened the use of cardiovascular imaging through ultrasound devices.
UK is witnessing a growth of CVDs and other chronic diseases, which has fuelled the growth of Europe ultrasound devices market. Global players, Philips has introduced EPIQ elite, which is powered by AI and includes features such as auto doppler, enabling precision imaging to detect the affected area caused by the disease. The UK is one of the most sophisticated healthcare systems across the globe, which is monitored by the NHS to ensure patient satisfaction and care. The players in the UK market compete intensely to gain a higher share through innovation and product development. The large population levels and emerging chronic diseases among the population have significantly increased the scope for ultrasound devices.
Germany holds excellence in healthcare infrastructure, where it prefers modern equipment and awaits the opportunity to integrate advanced healthcare equipment for positive patient outcomes. The country has abolished the invasive image screening, propelling the growth of non-invasive screenings using 3D and 4D methods that help in enhancing the image quality and keeping the patients out of bleeding risks. The scope of telemedicine and remote monitoring has increased over time, supporting the expansion of portable ultrasound devices. The cumulative efforts of Germany to advance the healthcare infrastructure and remote monitoring has significantly enhance the Germany ultrasound devices market.
Key Ultrasound Devices Market Players:
- GE Healthcare (U.S.)
- Philips Healthcare (Netherlands)
- Siemens Healthineers (Germany)
- Canon Medical Systems (Japan)
- Mindray (China)
- FUJIFILM SonoSite (U.S.)
- Samsung Medison (South Korea)
- Hitachi Healthcare (Japan)
- Clarius Mobile Health (Canada)
- Esaote (Italy)
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Philips Healthcare: One of the oldest businesses across the globe that specialises in imaging technologies such as MRI and CT Scans. The business is also engaged in patient monitoring and care, where it manufactures patient monitoring systems for hospitals and diagnostic centres. It has presence across the globe with manufacturing plants located strategically across regions that supports in wider geographical footprint.
- Siemens Healthineers: A leading medical technology company that develops diagnostic treatments and AI-driven medical imaging solutions. The business also owns a laboratory diagnostic solution that helps in running tests through machines, enabling accurate and safer results. It has also integrated towards AI-based digital health monitoring that enables cloud-based patient monitoring.
- Samsung Medison: A firm that specialises in ultrasound technology that offers a wide range of diagnostic imaging solutions. The focus is made towards 3D and 4D imaging for better disease detection. The RS80A system is highly competitive in measuring the cardiological issues. It has a global footprint, serving major hospitals across the Asia Pacific and North America.
- FUJIFILM SonoSite: The business is one of the most trusted manufacturers of ultrasound imaging systems. The systems are compact and can be easily installed in hospitals, clinics, ambulances and residential settings. The products offer real-time imaging and rugged response, which is suitable in emergencies. The business has also made advancements in Doppler technology, which enhances the ultrasound quality and images.
- Hitachi Healthcare: A leading manufacturer of medical imaging and technology that aims to develop efficient systems and to enhance patient outcomes. The business is a strong player in oncology, cardiology and radiology screenings. The business developed Supria, a compact MRI system that can provide high-resolution images while minimising the operational cost of imaging.
Here is a list of key players operating in the global market:
The players operating in the ultrasound devices market are expected to face intense competition during the forecast period. The market is fragmented, with both top players and new entrants. With modern technology, further developments and better investments in the healthcare industry, the ultrasound devices market is projected to register vast expansion. Key players in the market are significantly supported by the governments for research and innovation.
Corporate Landscape of Ultrasound Devices Market:
Recent Developments
- In August 2025, GE Healthcare launched Vivid Pioneer,ultra-premium and adaptive cardiovascular ultrasound system, redesigned to support clinicians with extraordinary imaging in 2D, 4D and color flow.
- In January 2023, Fujifilm SonoSite developed SonoSite PX, a high-performance ultrasound device that can deliver high-resolution images in emergency and operating rooms. The product can seamlessly monitor the patient's condition remotely, enhancing patient care.
- In 2023, Philips expanded its remote monitoring portfolio by acquiring Biotelemetry, specialising in cardiovascular monitoring. The deal was signed at USD 2.8 billion, which focuses on chronic disease management remotely using remote ultrasound devices.
- Report ID: 4097
- Published Date: Feb 10, 2026
- Report Format: PDF, PPT
- Explore a preview of key market trends and insights
- Review sample data tables and segment breakdowns
- Experience the quality of our visual data representations
- Evaluate our report structure and research methodology
- Get a glimpse of competitive landscape analysis
- Understand how regional forecasts are presented
- Assess the depth of company profiling and benchmarking
- Preview how actionable insights can support your strategy
Explore real data and analysis
Frequently Asked Questions (FAQ)
Ultrasound Devices Market Report Scope
Free Sample includes current and historical market size, growth trends, regional charts & tables, company profiles, segment-wise forecasts, and more.
Connect with our Expert
Copyright @ 2026 Research Nester. All Rights Reserved.
